Jump to Navigation

Facebook Connect

User login

Epidemiology and Nomenclature


Chapter 1: Epidemiology and Nomenclature

This slide module will give an overview of the epidemiology of HDL, the history of HDL-C as a therapeutic target, how HDL-C is associated with CVD Outcomes and an overview of measures of HDL quantity.

FACULTY

Chair
Peter P. Toth, MD, PhD, FNLA

Co-chair
Rachel H. Mackey, PhD, MPH

Co-chair
Richard H. Karas, MD, PhD


View Slides with Notes Download Full Size Slides Download Slides with Notes
0
No votes yet
Activity Classification

This activity is instructional only and may not be taken for credit.

Content Domain
This activity falls under the following content domain(s):

Learning Objectives
This activity teaches to the following learning objective(s):

  1. Evaluate the role of HDL-C in reducing cardiovascular events and rates of atherosclerotic disease progression
  2. For Registered Nurses and Nurse Practitioners Only: Provide appropriate care and counsel for patients and their families



by Dr. Radut.